INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.85 Cr | ₹0.91 Cr | ₹0.14 Cr | ₹-0.08 Cr | ₹-0.07 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDO US BIOTECH ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-0.85 Cr |
| Mar2024 | ₹0.91 Cr |
| Mar2023 | ₹0.14 Cr |
| Mar2022 | ₹-0.08 Cr |
| Mar2021 | ₹-0.07 Cr |
How is Net Cash Inflow / Outflow of INDO US BIOTECH Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.85 Cr | Negative | |
| Mar2024 | ₹0.91 Cr | 544.68 | |
| Mar2023 | ₹0.14 Cr | Positive | |
| Mar2022 | ₹-0.08 Cr | Negative | |
| Mar2021 | ₹-0.07 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹211.1 Cr | -2.7% | 1.8% | -38.2% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,762.0 Cr | 0.9% | 2% | -18.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,854.3 Cr | 2.1% | 23.2% | -38.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,205.3 Cr | -1.5% | 26% | -6.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,048.4 Cr | -0.4% | 26.5% | -24.2% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹460.1 Cr | 8% | 37.5% | -1.3% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -2.7% |
1.8% |
-38.2% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses